ViRexx Announces Encouraging Results From Its Lead ChimigenTM Therapeutic Vaccine Candidate For Treating Chronic Hepatitis B Virus Infections
August 25th, 2008 by 
admin ViRexx Medical Corp. (TSX:VIR) (AMEX:REX), consort convergent on nonindustrial innovative-targeted therapeutic products that substance meliorate calibre of chronicle and a renewed wish for living.
Tags: Focus
Posted in Immunology | 